AMRI has more than doubled its current bulk Active Pharmaceutical Ingredient (API) aseptic manufacturing capacity with the addition of a new multipurpose aseptic line at its facility in Valladolid, Spain. This augments its aseptic API manufacturing plants in Bon Encontre and Tonneins, France.   The sterilization capability can be integrated with API production or operate as a separate outsourced step for customers that do not have bulk sterile facilities or need additional capacity. Supporting...